Slentrol

RSS

dirlotapide

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 24/02/2015

Authorisation details

Product details
Name
Slentrol
Agency product number
EMEA/V/C/000116
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QA08AB91
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
13/04/2007
Contact address
Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

15/01/2015 Slentrol - EMEA/V/C/000116 - IAIN/0007/G

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Anti obesity preparations
  • excluding diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Assessment history

How useful was this page?

Add your rating